Transparent PBM Washington Employer Pharmacy Costs: How to Stop Overpaying for Prescriptions

Your prescription drug plan may be paying two prices at once: the price shown on the renewal and the hidden price buried inside the pharmacy benefit manager contract. For many Washington employers, that hidden price shows up as spread pricing, retained rebates, specialty pharmacy markups, and reporting gaps that make pharmacy spend look unavoidable. A transparent PBM Washington employer pharmacy costs review turns that black box into a vendor relationship your leadership team can measure, negotiate, and improve.

Want to know whether your PBM contract is leaking money? Request a free pharmacy spend audit from Washington Health Insurance Agency. WHIA can review your current arrangement, identify the questions your vendor should answer, and show where a transparent contract could reduce waste.

This guide explains how opaque PBM arrangements hide costs, which contract terms Washington employers should audit, how much savings may be possible, and how WHIA sources transparent pharmacy solutions without disrupting the broader benefits strategy.

Why PBM Transparency Matters More in Washington Renewals

Pharmacy is no longer a small line item inside the health plan renewal. Employers are already managing higher medical premiums, wage pressure, and employees who expect strong prescription coverage. Pharmacy trend can make that pressure worse. Mercer reported that pharmacy benefit cost rose 7.7% in 2024 after an 8.4% increase in 2023, making prescription drugs the fastest-growing component of employer health benefit cost. Aetna also warned Washington employers that pharmacy expenses were projected to rise 10% to 12% compared with a 4.5% overall per-capita health care cost increase.

Those increases do not hit every plan the same way. A company covering specialty medications, GLP-1 drugs, oncology therapies, or employees with chronic conditions can see pharmacy spend move faster than the medical trend. If the PBM contract is opaque, leadership may only see the final renewal number, not the fees, spreads, rebates, and utilization patterns behind it.

That is why pharmacy deserves its own review during renewal. A broker who only compares carrier premiums may miss one of the biggest controllable cost centers inside the plan. WHIA treats pharmacy as part of the overall funding strategy, not as a side note.

How Opaque PBM Contracts Hide Employer Pharmacy Costs

A pharmacy benefit manager sits between the health plan, drug manufacturers, pharmacies, and members. In theory, the PBM negotiates discounts, manages formularies, processes claims, and helps control prescription drug costs. In practice, the contract determines whether those savings flow back to the employer or stay inside the PBM arrangement.

Spread Pricing

Spread pricing happens when the PBM charges the plan more for a prescription than it reimburses the pharmacy, then keeps the difference. The employer may see a claim cost that looks normal, while the pharmacy received less than the plan paid. Without claim-level reporting, the spread can be almost impossible to measure.

Rebate Retention

Manufacturers often pay rebates in exchange for preferred formulary placement. In a transparent arrangement, the employer can see what rebates were collected and how much was passed through. In an opaque arrangement, the PBM may retain a portion of rebates or define “rebate” narrowly so other manufacturer payments are excluded.

Specialty Pharmacy Markups

Specialty drugs can represent a small share of prescriptions but a large share of total cost. If the PBM owns or controls the specialty pharmacy, contract incentives may favor higher-margin dispensing channels. Employers should know whether they can use independent specialty options and whether acquisition cost, dispensing fees, and clinical support are clearly reported.

Formulary Steering

Some formularies favor drugs with larger rebates rather than the lowest net cost to the plan. That can increase employer spend and employee out-of-pocket costs even when the PBM claims to be negotiating discounts. Transparent contracts should make formulary incentives visible.

What a Transparent PBM Contract Should Include

A transparent PBM contract does not mean the arrangement is simple. It means the employer can see enough data to make informed decisions. For Washington employers, the following provisions are the starting point.

• Pass-through pricing: The PBM charges the plan what the pharmacy is paid, plus a clearly stated administrative fee.
• 100% rebate pass-through: Manufacturer rebates and related payments are disclosed and returned to the plan, not quietly retained.
• Audit rights: The employer or its advisor can audit claims, pharmacy reimbursements, rebates, and contract performance.
• Claim-level reporting: The plan receives usable data by drug, pharmacy, member tier, ingredient cost, dispensing fee, and net cost.
• Specialty pharmacy flexibility: The employer can evaluate independent specialty pharmacy options when appropriate.
• Clear fee schedule: Administrative fees, clinical program fees, mail-order fees, and performance guarantees are stated plainly.
• No gag clauses: The employer has the right to review and discuss pricing, spreads, and rebate information with its advisor.

These terms help shift the PBM from a black box to a measurable vendor relationship. The goal is not to chase the lowest fee on paper. The goal is to understand total net pharmacy cost after discounts, rebates, fees, member impact, and clinical outcomes.

PBM Contract Audit Checklist for Washington Employers

Before renewing a health plan or accepting a PBM proposal, ask for a focused pharmacy contract audit. WHIA typically looks at contract terms, claims data, renewal assumptions, and vendor reporting to answer practical questions.

1. What Is the True Net Cost?

Review gross drug cost, pharmacy reimbursement, rebates, administrative fees, and member cost sharing. A plan that looks cheaper before rebates may cost more after all money flows are included.

2. Are Rebates Fully Defined?

Contract language matters. If “rebates” excludes administrative credits, data fees, inflation payments, or other manufacturer compensation, the PBM may keep money the employer assumes is being passed through.

3. Can the Employer Audit Spread Pricing?

Ask whether the plan can compare what it paid against what pharmacies received. If the PBM refuses to provide the data, that is a red flag.

4. Who Controls Specialty Pharmacy?

Review specialty drug pricing, network requirements, prior authorization rules, and whether the employer can carve out certain categories. Specialty pharmacy can be one of the largest savings opportunities.

5. Does the Formulary Serve the Plan or the PBM?

Look beyond brand-name discounts. Evaluate lowest net cost alternatives, generic utilization, biosimilar strategy, step therapy rules, and member disruption.

6. What Happens at Renewal?

Transparent vendors should provide performance reviews throughout the year, not just at renewal. The employer should know what changed, which drugs drove trend, and which actions can reduce next year’s cost.

How Much Can Transparent PBM Contracts Save?

Actual savings depend on plan size, claims history, specialty drug utilization, current PBM terms, and whether the employer is fully insured, level-funded, or self-funded. Industry examples often show transparent PBM or direct pharmacy models reducing pharmacy costs by 10% to 25%. More conservative renegotiations may produce 5% to 15% savings when the employer keeps the same general structure but improves rebate pass-through, fees, and audit rights.

For a Washington employer spending $500,000 annually on pharmacy claims, even a 10% improvement can represent $50,000 in annual savings. For larger groups or plans with specialty drug exposure, the opportunity can be much higher. The only responsible way to estimate savings is to audit the current contract and claims data.

There is also a strategic benefit beyond the first-year savings estimate. Transparent reporting gives the employer better renewal leverage, cleaner benchmarking, and earlier warning when one therapeutic class or specialty medication category starts driving trend. That information can shape plan design, employee education, prior authorization strategy, and funding decisions before the next renewal arrives.

Mid-renewal is the right time to start. Ask WHIA for a free pharmacy spend audit before your renewal package locks you into another year of unclear PBM economics.

How WHIA Sources Transparent PBM Contracts

Washington Health Insurance Agency works differently from volume-driven brokerages. WHIA serves Washington businesses with senior-level guidance, year-round strategy, and a fee structure designed to align with savings rather than premium increases. That matters when pharmacy contracts need real scrutiny.

WHIA evaluates pharmacy arrangements as part of the broader benefits strategy, including large group health insurance, level-funded health plans, self-funded options, captives, HRAs, and carrier renewals. The objective is not to swap vendors for the sake of change. The objective is to identify the funding model and PBM structure that gives the employer better control.

When reviewing PBM options, WHIA helps employers compare:

• Traditional carrier-integrated PBM arrangements
• Transparent pass-through PBM models
• Independent pharmacy benefit solutions
• Specialty pharmacy carve-out opportunities
• Formulary and clinical management strategies
• Member experience, access, and disruption risk

This is especially important for Washington employers with 20 to 300 employees. Many are large enough to have meaningful pharmacy spend but not large enough to maintain an internal benefits analytics team. WHIA fills that gap with market access, contract review, and practical recommendations.

When Should an Employer Review Its PBM Contract?

The best time is before renewal, but several triggers should prompt a review sooner.

• Your health plan renewal increased faster than wages or revenue.
• Pharmacy spend is rising faster than medical spend.
• Employees are complaining about prescription access or high copays.
• Your PBM will not provide claim-level reporting.
• Your contract does not clearly state rebate pass-through terms.
• Specialty drug costs are driving a large share of claims.
• You are considering a move to level-funded or self-funded coverage.
• You changed brokers, carriers, or funding models and never reviewed pharmacy separately.

Employers should also review PBM terms when changing brokers. A new broker should not only quote carriers. They should inspect the cost structure inside the plan and explain where the current arrangement helps or hurts the company.

Transparent PBM Questions to Ask Your Broker

If your broker cannot answer these questions, your PBM arrangement may not be receiving enough attention.

• How much did our plan spend on pharmacy claims last year?
• What percentage of spend came from specialty drugs?
• How much rebate money was collected and passed back to the plan?
• Does our PBM use spread pricing?
• Can we audit pharmacy reimbursements at the claim level?
• Are all PBM fees fixed and disclosed?
• Which formulary changes could lower net cost without harming employees?
• Could a transparent PBM, carve-out, level-funded plan, or self-funded strategy improve our economics?

These questions are not academic. They determine whether the employer is managing pharmacy as a strategic cost center or accepting whatever number appears in the renewal. They also reveal whether the broker is acting as a renewal processor or a year-round advisor.

WHIA’s broader model is built around that year-round advisory role. Businesses that want senior-level support, transparent economics, and practical savings strategy can also review the top reasons Washington businesses choose WHIA for employee benefits guidance.

Frequently Asked Questions About Transparent PBM Contracts

What is a transparent PBM?

A transparent PBM is a pharmacy benefit manager that clearly discloses pricing, rebates, fees, pharmacy reimbursements, and performance data. The PBM typically earns a fixed administrative fee instead of profiting from hidden spreads or retained rebates.

Does every Washington employer need a separate PBM?

No. The right structure depends on the size of the group, funding model, claims data, and carrier arrangement. Some employers should improve terms inside the current plan. Others may benefit from a transparent PBM or pharmacy carve-out.

How much can employers save with a transparent PBM contract?

Many employers see potential pharmacy savings in the 5% to 25% range, depending on current contract terms and utilization. WHIA starts with an audit because savings should be estimated from actual claims data, not a generic promise.

Will changing PBM arrangements disrupt employees?

It can if the transition is handled poorly. WHIA evaluates network access, formulary disruption, specialty medication needs, and employee communication before recommending a change.

What data is needed for a PBM audit?

A useful audit usually starts with the current PBM contract, recent claims or renewal reporting, rebate summaries, specialty pharmacy reporting, formulary information, and any vendor fee schedules. WHIA can help identify what to request if the current vendor has not provided complete data.

Start With a Free Pharmacy Spend Audit

Transparent PBM contracts can help Washington employers stop overpaying for prescription drugs, but the first step is not signing a new vendor agreement. The first step is understanding the contract you already have.

WHIA can review your current pharmacy arrangement, identify hidden cost drivers, and show whether a transparent PBM contract, level-funded plan, self-funded plan, or carrier-integrated solution makes the most sense for your company.

Ready to see what your prescription plan is really costing? Schedule a free pharmacy spend audit with Washington Health Insurance Agency. Keep your plan if it works. Upgrade the strategy behind it.